Home / Inspections / 1002516

FDA Inspection 1002516 — Island Reproductive Services

Island Reproductive Services — FEI 3011393636

The FDA completed an inspection of Island Reproductive Services on February 16, 2017 in Staten Island, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 16, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Staten Island, NY (United States)

Facility

Other inspections at this facility

  • 1267810 (NAI Thu Apr 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1195562 (VAI Thu Jan 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102408 (NAI Thu Sep 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921812 (VAI Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 830435 (NAI Fri May 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources